ADL Bionatur Solutions, S.A. Stock price BME
Equities
Biotechnology & Medical Research
Sales 2021 | 3.28M 3.54M | Sales 2022 | 2.96M 3.19M | Capitalization | 12.42M 13.4M |
---|---|---|---|---|---|
Net income 2021 | -3M -3.24M | Net income 2022 | -1M -1.08M | EV / Sales 2021 | 8.37 x |
Net Debt 2021 | 6.53M 7.05M | Net Debt 2022 | 7.45M 8.03M | EV / Sales 2022 | 6.72 x |
P/E ratio 2021 |
-6.95
x | P/E ratio 2022 |
-6.41
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 51.48% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | 60 | 19-10-31 | |
Javier Uría
COO | Chief Operating Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | - | - | |
Director/Board Member | - | - | |
John Dixon
BRD | Director/Board Member | 68 | - |
1st Jan change | Capi. | |
---|---|---|
+2.73% | 108B | |
+9.59% | 104B | |
+6.58% | 23.66B | |
-12.59% | 22.1B | |
-3.29% | 19.71B | |
-35.36% | 18.2B | |
-13.29% | 16.19B | |
+4.68% | 13.72B | |
+34.25% | 12.22B |